IN2012DN00857A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00857A IN2012DN00857A IN857DEN2012A IN2012DN00857A IN 2012DN00857 A IN2012DN00857 A IN 2012DN00857A IN 857DEN2012 A IN857DEN2012 A IN 857DEN2012A IN 2012DN00857 A IN2012DN00857 A IN 2012DN00857A
- Authority
- IN
- India
- Prior art keywords
- pth
- excellent safety
- drug
- achievement
- inhibiting
- Prior art date
Links
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 208000010392 Bone Fractures Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003442 weekly effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009208039 | 2009-09-09 | ||
| PCT/JP2010/065379 WO2011030774A1 (ja) | 2009-09-09 | 2010-09-08 | １回当たり１００～２００単位のｐｔｈが週１回投与されることを特徴とする、ｐｔｈ含有骨粗鬆症治療／予防剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00857A true IN2012DN00857A (enExample) | 2015-07-10 |
Family
ID=43732444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN857DEN2012 IN2012DN00857A (enExample) | 2009-09-09 | 2010-09-08 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US20120252729A1 (enExample) |
| EP (3) | EP2476429B1 (enExample) |
| JP (13) | JPWO2011030774A1 (enExample) |
| KR (8) | KR20170089018A (enExample) |
| CN (2) | CN103893746A (enExample) |
| AU (1) | AU2010293488B2 (enExample) |
| BR (1) | BR112012003511A2 (enExample) |
| CA (1) | CA2772656A1 (enExample) |
| ES (3) | ES2662018T3 (enExample) |
| IL (1) | IL217854A (enExample) |
| IN (1) | IN2012DN00857A (enExample) |
| MX (1) | MX335951B (enExample) |
| NZ (2) | NZ598370A (enExample) |
| RU (1) | RU2564894C2 (enExample) |
| WO (1) | WO2011030774A1 (enExample) |
| ZA (1) | ZA201201720B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2502632B1 (en) * | 2009-11-18 | 2016-12-28 | Asahi Kasei Pharma Corporation | Preventative agent and/or therapeutic agent and/or exacerbation-suppressing agent for human knee osteoarthritis |
| JP6235219B2 (ja) * | 2013-03-21 | 2017-11-22 | 旭化成ファーマ株式会社 | 脊椎椎体間固定術後の骨癒合促進剤 |
| US10394953B2 (en) | 2015-07-17 | 2019-08-27 | Facebook, Inc. | Meme detection in digital chatter analysis |
| JP2020506926A (ja) * | 2017-02-01 | 2020-03-05 | ザ・ジョンズ・ホプキンス・ユニバーシティ | 副甲状腺ホルモンと変性椎間板疾患の再生 |
| WO2019059303A1 (ja) * | 2017-09-22 | 2019-03-28 | 旭化成ファーマ株式会社 | 薬物動態及び／又は安全性に優れるテリパラチド含有液状医薬組成物 |
| JP2019060866A (ja) * | 2017-09-22 | 2019-04-18 | 旭化成ファーマ株式会社 | 液状医薬組成物の体内動態を予測する方法 |
| US20200289621A1 (en) * | 2017-09-22 | 2020-09-17 | Asahi Kasei Pharma Corporation | Teriparatide-containing liquid pharmaceutical composition having excellent stability |
| CN111447943A (zh) | 2018-10-29 | 2020-07-24 | 旭化成制药株式会社 | 以按每周2次的频率给予特立帕肽或其盐为特征的骨质疏松症的预防或治疗方法 |
| KR102920552B1 (ko) * | 2024-01-03 | 2026-01-30 | 김도영 | 나노입자경의 탄산칼슘과 탄산마그네슘 제조방법 및 그 방법으로 제조된 골다공증 예방치료제 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2505812B2 (ja) | 1987-07-10 | 1996-06-12 | 旭化成工業株式会社 | ｈ―ＰＴＨ（１―３４）凍結乾燥組成物 |
| JP2662842B2 (ja) | 1991-12-09 | 1997-10-15 | 旭化成工業株式会社 | パラサイロイドホルモンの安定化組成物 |
| JPH0873376A (ja) | 1994-09-07 | 1996-03-19 | Asahi Chem Ind Co Ltd | 骨粗鬆症治療薬 |
| SE9702401D0 (sv) * | 1997-06-19 | 1997-06-19 | Astra Ab | Pharmaceutical use |
| MY120063A (en) * | 1997-12-09 | 2005-08-30 | Lilly Co Eli | Stabilized teriparatide solutions |
| AR033639A1 (es) | 1998-08-19 | 2004-01-07 | Lilly Co Eli | Uso de hormonas paratiroideas para preparar medicamentos para reducir el riesgo de fracturas oseas vertebrales o no vertebrales en seres humanos con riesgo de padecer o que padecen osteoporosis |
| US6756480B2 (en) * | 2000-04-27 | 2004-06-29 | Amgen Inc. | Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| BR0112381A (pt) | 2000-06-30 | 2003-05-06 | Suntory Ltd | Componente farmacêutico com base em hormÈnio da paratireóide humana e uma composição farmacêutica para administração intranasal compreendendo o componente |
| JP5042419B2 (ja) * | 2001-08-15 | 2012-10-03 | 旭化成ファーマ株式会社 | 骨形成促進剤および骨形成促進組成物 |
| JP4931306B2 (ja) | 2001-09-27 | 2012-05-16 | 旭化成ファーマ株式会社 | 骨形成を安全に促進させる医薬複合剤 |
| JP2007525472A (ja) * | 2003-07-04 | 2007-09-06 | ニコメド ダンマーク エイピーエス | 経口使用のための副甲状腺ホルモン（ｐｔｈ）含有医薬組成物 |
| JPWO2005102381A1 (ja) * | 2004-04-26 | 2008-03-06 | 小野薬品工業株式会社 | カテプシンｋ阻害薬およびｐｔｈ類を併用することを特徴とする骨密度増加剤 |
| US7244709B2 (en) * | 2004-05-10 | 2007-07-17 | Nastech Pharamecutical Company Inc. | Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| US7799754B2 (en) * | 2004-10-14 | 2010-09-21 | Biomimetic Therapeutics, Inc. | Compositions and methods for treating bone |
| JP2006241098A (ja) * | 2005-03-04 | 2006-09-14 | Univ Kurume | 骨量減少症の予防または治療薬 |
| DE102006043846A1 (de) * | 2006-03-14 | 2007-09-20 | Claudia Zours | Wirbelsäulenorthesen |
| WO2007106597A2 (en) * | 2006-03-15 | 2007-09-20 | Alza Corporation | Method for the transdermal delivery of parathyroid hormone agents for treating osteopenia |
| CN101274961A (zh) * | 2006-03-30 | 2008-10-01 | 天津医科大学 | 重组人甲状旁腺素相关蛋白 |
| CN101125201A (zh) * | 2006-08-17 | 2008-02-20 | 石家庄欧意药业有限公司 | 治疗骨质疏松症或防治由于骨质疏松而导致的骨折的药物组合物及其应用 |
| CN101307105B (zh) * | 2008-04-28 | 2012-08-29 | 中国药科大学 | 一种能串联表达和同步酸水解释放的人甲状旁腺素1-34肽类似物及其制备方法和应用 |
-
2010
- 2010-09-08 ES ES13181713.2T patent/ES2662018T3/es active Active
- 2010-09-08 EP EP10815369.3A patent/EP2476429B1/en active Active
- 2010-09-08 MX MX2012002681A patent/MX335951B/es unknown
- 2010-09-08 IN IN857DEN2012 patent/IN2012DN00857A/en unknown
- 2010-09-08 AU AU2010293488A patent/AU2010293488B2/en active Active
- 2010-09-08 KR KR1020177019824A patent/KR20170089018A/ko not_active Ceased
- 2010-09-08 KR KR1020177019823A patent/KR20170089017A/ko not_active Ceased
- 2010-09-08 KR KR1020127005972A patent/KR20120067336A/ko not_active Ceased
- 2010-09-08 EP EP13181715.7A patent/EP2682125B1/en active Active
- 2010-09-08 JP JP2011530844A patent/JPWO2011030774A1/ja active Pending
- 2010-09-08 ES ES10815369.3T patent/ES2663322T3/es active Active
- 2010-09-08 KR KR20157003153A patent/KR20150021590A/ko not_active Ceased
- 2010-09-08 WO PCT/JP2010/065379 patent/WO2011030774A1/ja not_active Ceased
- 2010-09-08 KR KR1020197023161A patent/KR20190095552A/ko not_active Ceased
- 2010-09-08 ES ES13181715T patent/ES2843649T3/es active Active
- 2010-09-08 US US13/395,000 patent/US20120252729A1/en not_active Abandoned
- 2010-09-08 CN CN201410092512.5A patent/CN103893746A/zh active Pending
- 2010-09-08 BR BR112012003511A patent/BR112012003511A2/pt not_active IP Right Cessation
- 2010-09-08 KR KR20147029471A patent/KR20140130754A/ko not_active Withdrawn
- 2010-09-08 NZ NZ598370A patent/NZ598370A/en unknown
- 2010-09-08 EP EP13181713.2A patent/EP2682124B1/en active Active
- 2010-09-08 RU RU2012108635/15A patent/RU2564894C2/ru active
- 2010-09-08 CA CA2772656A patent/CA2772656A1/en not_active Abandoned
- 2010-09-08 KR KR1020207027785A patent/KR102335703B1/ko active Active
- 2010-09-08 CN CN201080034494.5A patent/CN102470164B/zh active Active
- 2010-09-08 KR KR1020217009475A patent/KR102424644B1/ko active Active
- 2010-09-08 NZ NZ617397A patent/NZ617397A/en unknown
-
2012
- 2012-01-31 IL IL217854A patent/IL217854A/en active IP Right Grant
- 2012-03-08 ZA ZA2012/01720A patent/ZA201201720B/en unknown
-
2014
- 2014-03-05 US US14/197,607 patent/US20140249084A1/en not_active Abandoned
- 2014-07-14 US US14/330,124 patent/US20140357560A1/en not_active Abandoned
-
2015
- 2015-05-25 JP JP2015105265A patent/JP6150846B2/ja active Active
- 2015-05-25 JP JP2015105266A patent/JP6198346B2/ja active Active
-
2016
- 2016-04-18 JP JP2016082589A patent/JP6043008B2/ja active Active
- 2016-11-10 JP JP2016219323A patent/JP2017061511A/ja active Pending
-
2017
- 2017-03-27 JP JP2017061093A patent/JP6301524B2/ja active Active
- 2017-03-27 JP JP2017061094A patent/JP2017105861A/ja not_active Withdrawn
- 2017-03-27 JP JP2017061091A patent/JP6275900B2/ja active Active
- 2017-03-27 JP JP2017061096A patent/JP2017105863A/ja active Pending
- 2017-03-27 JP JP2017061095A patent/JP2017105862A/ja not_active Withdrawn
- 2017-03-27 JP JP2017061092A patent/JP6274634B2/ja active Active
- 2017-11-17 JP JP2017221570A patent/JP6522715B2/ja active Active
-
2018
- 2018-11-16 JP JP2018215152A patent/JP2019023234A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX335951B (es) | Agente terapeutico/profilactico que contiene pth para la osteoporosis, caracterizado porque la pth se administra una vez a la semana en una dosis unitaria de 100 a 200 unidades. | |
| TN2012000143A1 (en) | Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof | |
| PH12014501560A1 (en) | Carbamate compounds and of making and using same | |
| MX363243B (es) | Composiciones para tratar cáncer y usos de dichas composiciones. | |
| MX2013013809A (es) | Dispositivos expandibles con revestimiento de una composicion de paclitaxel. | |
| IN2015DN03219A (enExample) | ||
| MX338554B (es) | Compuestos de fenil carbamato para usarse en aliviar o tratar el dolor. | |
| PH12012500773A1 (en) | A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof | |
| SA113340494B1 (ar) | تركيبة لعلاج اضطرابات أيضية | |
| DE502005005636D1 (en) | Spirocyclische cyclohexan-derivate | |
| MX2013008074A (es) | Combinacion. | |
| MX341660B (es) | Agonista del receptor de ghrelina para el tratamiento de caquexia. | |
| MX2013013808A (es) | Dispositivos expandibles con revestimiento de una composicion de rapamicina. | |
| IN2014DN09779A (enExample) | ||
| MX339484B (es) | Agente preventivo y/o agente terapeutico y/o agente supresivo del agravamiento para la artritis humana deformante. | |
| MX2014015096A (es) | Alimento para crustaceos. | |
| AU2014230304A8 (en) | Complex preparation including valsartan and rosuvastatin calcium and manufacturing method therefor | |
| WO2012011673A3 (ko) | 헤스페레틴을 유효성분으로 포함하는 근육세포 분화 또는 재생 촉진용 약학적 조성물 | |
| WO2011089531A3 (en) | Effects of the association of vitamin k2 and vitamin d3 in the consolidation of a bone fracture | |
| MX2014013491A (es) | Metodos para mantener, tratar o mejorar la funcion cognitiva. | |
| WO2011136585A3 (ko) | 글리세올린을 유효성분으로 포함하는 골질환 치료용 조성물 | |
| UA56460U (ru) | Способ лечения травматических повреждений периферического нерва | |
| UA53407U (ru) | Способ профилактики и лечения перенашевания беременности | |
| MX2012012712A (es) | Composicion farmaceutica para uso en el tratamiento o prevencion de una o varias enfermedaes inflamatorias y/o enfermedades autoinmunitarias. | |
| MD10Z (ro) | Metodă de tratament al pielonefritei gestaţionale |